Risk factors for antipsychotic- and antidepressant-associated liver function abnormalities
Antipsychotics (APs) and antidepressants (ADs) are the primary therapies for psychiatric disorders. However, drug-induced liver injury and liver biochemical abnormalities during treatment with APs and/or ADs remain significant safety concerns in clinical practice. Identifying factors associated with liver function abno...